Shots: Merck will acquire all outstanding shares of Themis in exchange for an undisclosed cash payment. The acquisition follows the ongoing collaboration between the two companies to develop vaccine candidates […]readmore
Tags : Developing
Shots: Ironwood to receive three non-contingent payment of $35M b/w 2021 & 2024, ~$90M as a milestone with royalties on sales of Linzess in China mainland, China Hong Kong and […]readmore
Shots: Vertex acquires Semma Therapeutics, in all cash transaction making a total deal value $950M and Semma will operate as a subsidiary of Vertex. The transaction is expected to be […]readmore
Shots: REGENXBIO plans to construct a cGMP manufacturing facility in Rockville, Maryland to produce gene therapy vectors based on NAV technology at scales up to 2,000L using its platform suspension […]readmore